Content area

|
|

Kombinationsbehandling med thyroxin og trijodthyronin til patienter med hypotyreose

Forfatter(e)

Birte Nygaard1, Michael E. Røder2, Jesper Karmisholt3 & Jette Kolding Kristensen4

1) Endokrinologisk Sektion, Medicinsk Afdeling, Herlev og Gentofte Hospital 2) Medicinsk Afdeling, Herlev og Gentofte Hospital 3) Endokrinologisk Afdeling, Medicinerhuset, Aalborg Universitetshospital 4) Center for Forskning og Uddannelse i Almen Medicin, Klinisk Institut, Aalborg Universitet Ugeskr Læger 2018;180:V04170328

Reference: 
Ugeskr Læger 2018;180:V04170328
Blad nummer: 
Sidetal: 
2-5
Combination therapy of thyroxine and triiodothyronine in hypothyroid patients

Decreased quality of life is described more often in hypothyroid patients, who are treated with a synthetic form of thyroxine (L-T4), than in euthyroid controls. A combination of L-T4 and a synthetic form of triiodothyronine (L-T3) has been suggested; however, previous meta-analyses on unselected patients did not find any effect. Recent studies demonstrate, that the overall hypothalamic-pituitary-thyroid-tissue homeostasis could be more complex than previously suggested. Polymorphisms in deiodinase and thyroid hormone transporter genes could theoretically explain, why a minor subgroup of hypothyroid patients seem to have an effect of L-T4/L-T3 combination therapy.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Eskild Boeskov | 23/01
6 kommentarer
af Pal Bela Szecsi | 20/01
2 kommentarer
af Peter Søndergaard | 18/01
3 kommentarer
af Mads Henrik Koch Hansen | 16/01
2 kommentarer
af Lars Guttorm | 14/01
5 kommentarer
af Morten Ellemose Gulev | 14/01
4 kommentarer
af Henning Damgaard Laugesen | 14/01
1 Kommentar